Novartis in warning over South Korea
Novartis is at the heart of a bitter dispute between the international pharmaceuticals industry and the South Korean government over drug pricing. The Swiss company has warned that South Korean
Novartis is at the heart of a bitter dispute between the international pharmaceuticals industry and the South Korean government over drug pricing. The Swiss company has warned that South Korean